Literature DB >> 21373885

How does the genetic assassin select its neuronal target?

James C Stevens1, Elizabeth M C Fisher, Simon Mead.   

Abstract

Through many different routes of analysis, including human familial studies and animal models, we are identifying an increasing number of genes that are causative for human neurodegenerative disease and are now in a position for many such disorders to dissect the molecular pathology that gives rise to neuronal death. Yet a paradox remains: The majority of the genes identified cause neurodegeneration in specific neuronal subtypes, but the genes themselves are ubiquitously expressed. Furthermore, the different mutations in the same gene may cause quite different types of neurodegeneration. Something in our understanding of neurodegenerative disease is clearly missing, and we refer to this as the phenomenon of "neuronal targeting." Here we discuss possible explanations for neuronal targeting, why specific neuronal subtypes are vulnerable to specific mutations in ubiquitously expressed genes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21373885     DOI: 10.1007/s00335-011-9319-5

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  67 in total

Review 1.  Amyotrophic lateral sclerosis as a complex genetic disease.

Authors:  Claire L Simpson; Ammar Al-Chalabi
Journal:  Biochim Biophys Acta       Date:  2006-08-05

2.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

3.  Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease.

Authors:  N Georgiou; J L Bradshaw; E Chiu; A Tudor; L O'Gorman; J G Phillips
Journal:  Mov Disord       Date:  1999-03       Impact factor: 10.338

Review 4.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

5.  A MicroRNA feedback circuit in midbrain dopamine neurons.

Authors:  Jongpil Kim; Keiichi Inoue; Jennifer Ishii; William B Vanti; Sergey V Voronov; Elizabeth Murchison; Gregory Hannon; Asa Abeliovich
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

6.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.

Authors:  Jia-Yi Li; Elisabet Englund; Janice L Holton; Denis Soulet; Peter Hagell; Andrew J Lees; Tammaryn Lashley; Niall P Quinn; Stig Rehncrona; Anders Björklund; Håkan Widner; Tamas Revesz; Olle Lindvall; Patrik Brundin
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

7.  Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.

Authors:  C Zuccato; A Ciammola; D Rigamonti; B R Leavitt; D Goffredo; L Conti; M E MacDonald; R M Friedlander; V Silani; M R Hayden; T Timmusk; S Sipione; E Cattaneo
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

8.  Apolipoprotein e genotype modifies the phenotype of Alzheimer disease.

Authors:  Jonathan M Schott; Basil H Ridha; Sebastian J Crutch; Daniel G Healy; James B Uphill; Elizabeth K Warrington; Martin N Rossor; Nick C Fox
Journal:  Arch Neurol       Date:  2006-01

9.  Transmission and spreading of tauopathy in transgenic mouse brain.

Authors:  Florence Clavaguera; Tristan Bolmont; R Anthony Crowther; Dorothee Abramowski; Stephan Frank; Alphonse Probst; Graham Fraser; Anna K Stalder; Martin Beibel; Matthias Staufenbiel; Mathias Jucker; Michel Goedert; Markus Tolnay
Journal:  Nat Cell Biol       Date:  2009-06-07       Impact factor: 28.824

10.  Continuous quinacrine treatment results in the formation of drug-resistant prions.

Authors:  Sina Ghaemmaghami; Misol Ahn; Pierre Lessard; Kurt Giles; Giuseppe Legname; Stephen J DeArmond; Stanley B Prusiner
Journal:  PLoS Pathog       Date:  2009-11-26       Impact factor: 6.823

View more
  1 in total

1.  A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.

Authors:  Emilia J Sitek; Ewa Narożańska; Beata Pepłońska; Sławomir Filipek; Anna Barczak; Maria Styczyńska; Krzysztof Mlynarczyk; Bogna Brockhuis; Erik Portelius; Dorota Religa; Maria Barcikowska; Jarosław Sławek; Cezary Żekanowski
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.